RxDoctor Payments Data

Nicholas Whipple

Pediatric Hematology-Oncology · Salt Lake City, UTNPI 1821315268

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $3,003 of the $3,258 with a category attached, or 92.2%. 5 manufacturers reported payments, led by Day One Biopharmaceuticals at 55.9% of the total. 2025 is the largest year on record at $2,055, 2.3 times the $900 reported in 2020.

$3,258in general payments, 2019–2025

Across 6 payments — averaging $543.04 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Day One Biopharmaceuticals$2K
  • Bayer$900
  • Beigene USA, Inc.$303
  • AstraZeneca$207
  • Novocure Inc.$25
$544,970in research payments, 2019–2025

Across 134 payments — averaging $4066.94 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Regeneron$415K
  • Day One Biopharmaceuticals$108K
  • Swedish Orphan Biovitrum AB$20K
  • F. Hoffmann-la Roche AG$2K

What the payments were for

  • Consulting fees$3,00392%
  • Food & beverage$2558%

General payments by program year

20
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,258 in reported general payments places this provider in the 75th percentile of 24 pediatric hematology-oncology providers in Utah.

See all pediatric hematology-oncology providers in Utah

Other pediatric hematology-oncology in Salt Lake City

See the full list for Utah

Where these figures come from

Is this you, or does something look wrong? →